GCKR and metabolic dysfunction-associated steatotic liver disease: Single nucleotide polymorphism of the GCKR rs1260326 alters the adiponectin function and influences the lipogenesis pathway to increase susceptibility and severity of NAFLD and hepatic fibrosis [13].